Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 948-960
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Figure 3 Overall survival and recurrence-free survival curve comparisons among patients without postoperative morbidity, with minor postoperative morbidity, and with major postoperative morbidity.
A: Overall survival, P = 0.231 (with minor postoperative morbidity vs without postoperative morbidity), P < 0.001 (with major postoperative morbidity vs without postoperative morbidity); B: Recurrence-free survival, P = 0.132 (with minor postoperative morbidity vs without postoperative morbidity), P < 0.001 (with major postoperative morbidity vs without postoperative morbidity).
- Citation: Liu ZP, Chen WY, Zhang YQ, Jiang Y, Bai J, Pan Y, Zhong SY, Zhong YP, Chen ZY, Dai HS. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol 2022; 28(9): 948-960
- URL: https://www.wjgnet.com/1007-9327/full/v28/i9/948.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i9.948